Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Divergent roles of HDAC1 and HDAC2 in the regulation of epidermal development and tumorigenesis.

Winter M, Moser MA, Meunier D, Fischer C, Machat G, Mattes K, Lichtenberger BM, Brunmeir R, Weissmann S, Murko C, Humer C, Meischel T, Brosch G, Matthias P, Sibilia M, Seiser C.

EMBO J. 2013 Dec 11;32(24):3176-91. doi: 10.1038/emboj.2013.243. Epub 2013 Nov 15.

2.

p19(ARF) /p14(ARF) controls oncogenic functions of signal transducer and activator of transcription 3 in hepatocellular carcinoma.

Schneller D, Machat G, Sousek A, Proell V, van Zijl F, Zulehner G, Huber H, Mair M, Muellner MK, Nijman SM, Eferl R, Moriggl R, Mikulits W.

Hepatology. 2011 Jul;54(1):164-72. doi: 10.1002/hep.24329.

PMID:
21452288
3.

A human model of epithelial to mesenchymal transition to monitor drug efficacy in hepatocellular carcinoma progression.

van Zijl F, Mall S, Machat G, Pirker C, Zeillinger R, Weinhaeusel A, Bilban M, Berger W, Mikulits W.

Mol Cancer Ther. 2011 May;10(5):850-60. doi: 10.1158/1535-7163.MCT-10-0917. Epub 2011 Mar 1.

4.

Epithelial-mesenchymal transition in hepatocellular carcinoma.

van Zijl F, Zulehner G, Petz M, Schneller D, Kornauth C, Hau M, Machat G, Grubinger M, Huber H, Mikulits W.

Future Oncol. 2009 Oct;5(8):1169-79. doi: 10.2217/fon.09.91. Review.

Supplemental Content

Loading ...
Support Center